Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1Prostatic Neoplasms 1Kidney Neoplasms 1Diverticulitis 1Crohn Disease 1Colonic Polyps 1Colonic Neoplasms 1Colitis, Ulcerative 1

Interventions

Certolizumab Pegol 5Infliximab 4Adalimumab 3Nivolumab 2MEDI2070 2vedolizumab 1secukinumab 1golimumab 1cabozantinib 1Vitamin E 1Vaccines 1Ustekinumab 1Sutures 1Surgical Instruments 1Specimen Handling 1Soybean Oil 1Saline Solution 1Ringer's Lactate 1Pneumococcal Vaccines 1Platinum Compounds 1Photoplethysmography 1Papillomavirus Vaccines 1Methoxsalen 1Medical Marijuana 1Lysine Acetyltransferase 5 1Iron-Dextran Complex 1Ipilimumab 1Indigo Carmine 1Hydroxyethyl Starch Derivatives 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Crohn Disease × Hydroxyethyl Starch Derivatives × Clear all
NCT00467922 2009-10-21

An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy

Corewell Health West

Phase 3 Completed
69 enrolled
Gastrointestinal

Colitis, Ulcerative, Colonic Neoplasms, Colonic Polyps, Crohn Disease, Diverticulitis, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡